Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shampa Das

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|April 4, 2018
Avibactam Pharmacokinetic/Pharmacodynamic TargetsWright W Nichols, Paul Newell, Ian A Critchley, et al.
Steroids|May 3, 2005
Binding characteristics, hormonal regulation and identity of the sperm membrane progestin receptor in Atlantic croakerPeter Thomas, Christopher Tubbs, Charles Detweiler, et al.
European Journal of Clinical Pharmacology|December 15, 2019
Selecting the dosage of ceftazidime-avibactam in the perfect storm of nosocomial pneumoniaShampa Das, Diansong Zhou, Wright W Nichols, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 17, 2015
Phase I study assessing the safety, tolerability, and pharmacokinetics of avibactam and ceftazidime-avibactam in healthy Japanese volunteersNobumitsu Tominaga, Timi Edeki, James Li, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2015
Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimensDavid P Nicolau, Leonard Siew, Jon Armstrong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 12, 2014
Assessment of the mass balance recovery and metabolite profile of avibactam in humans and in vitro drug-drug interaction potentialKarthick Vishwanathan, Stuart Mair, Anshul Gupta, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 9, 2025
Pharmacokinetics of Intrapartum Benzylpenicillin: Insights Into Candidate Regimens to Prevent Early Onset Neonatal Group B Streptococcus DiseaseBonniface Obura, Jennifer Unsworth, Ana Jimenez-Valverde, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2018
Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infectionsShampa Das, Jianguo Li, Joseph Iaconis, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2020
Considerations in the Selection of Renal Dosage Adjustments for Patients with Serious Infections and Lessons Learned from the Development of Ceftazidime-AvibactamJianguo Li, Mark Lovern, Todd Riccobene, et al.
Journal of Clinical Pharmacology|August 12, 2016
Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial PneumoniaTodd A Riccobene, Tatiana Khariton, William Knebel, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|April 4, 2018
Avibactam Pharmacokinetic/Pharmacodynamic TargetsWright W Nichols, Paul Newell, Ian A Critchley, et al.
Steroids|May 3, 2005
Binding characteristics, hormonal regulation and identity of the sperm membrane progestin receptor in Atlantic croakerPeter Thomas, Christopher Tubbs, Charles Detweiler, et al.
European Journal of Clinical Pharmacology|December 15, 2019
Selecting the dosage of ceftazidime-avibactam in the perfect storm of nosocomial pneumoniaShampa Das, Diansong Zhou, Wright W Nichols, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 17, 2015
Phase I study assessing the safety, tolerability, and pharmacokinetics of avibactam and ceftazidime-avibactam in healthy Japanese volunteersNobumitsu Tominaga, Timi Edeki, James Li, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2015
Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimensDavid P Nicolau, Leonard Siew, Jon Armstrong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 12, 2014
Assessment of the mass balance recovery and metabolite profile of avibactam in humans and in vitro drug-drug interaction potentialKarthick Vishwanathan, Stuart Mair, Anshul Gupta, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 9, 2025
Pharmacokinetics of Intrapartum Benzylpenicillin: Insights Into Candidate Regimens to Prevent Early Onset Neonatal Group B Streptococcus DiseaseBonniface Obura, Jennifer Unsworth, Ana Jimenez-Valverde, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2018
Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infectionsShampa Das, Jianguo Li, Joseph Iaconis, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2020
Considerations in the Selection of Renal Dosage Adjustments for Patients with Serious Infections and Lessons Learned from the Development of Ceftazidime-AvibactamJianguo Li, Mark Lovern, Todd Riccobene, et al.
Journal of Clinical Pharmacology|August 12, 2016
Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial PneumoniaTodd A Riccobene, Tatiana Khariton, William Knebel, et al.
Pageof 6